Clare Venter is a medical scientist with expertise in biomarker research and development within the global biotechnology and pharmaceutical industry. They served as an Assay Development Scientist at Roche from 2016 to 2017 and worked as a Senior Scientist at Synexa Life Sciences for a brief period in 2016. Currently, Clare is a Global Study Leader in Oncology at AstraZeneca, a position they have held since 2019. Clare earned a Bachelor’s degree, a BSc Honour degree, and a Master of Science from Stellenbosch University between 2007 and 2012.
This person is not in the org chart
This person is not in any teams
This person is not in any offices